PSTX
Price:
$9.5
Market Cap:
$925.93M
Poseida Therapeutics, Inc., a San Diego-based clinical-stage biopharmaceutical firm established in 2014, is dedicated to advancing novel therapeutic solutions for conditions with significant unmet medical needs. Its pipeline prominently features several advanced cell therapies. For instance, P-PSMA-101, an autologous CAR-T cell therapy, is currently undergoing Phase I clinical trials for individuals battling metastatic castrate-resistant prostate cancer (mCRPC). Additionally, Poseida is progressing two other CAR-T candidates through Phase I: P-BCMA-ALLO1 targets relapsed/refractory multiple myeloma, while P-MUC1C-ALLO1 is designed to address a variety of solid tumors, such as breast, ovarian...[Read more]
Industry
Biotechnology
IPO Date
2020-07-10
Stock Exchange
NASDAQ
Ticker
PSTX
According to Poseida Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -15.08. This represents a change of 1.08% compared to the average of -1.28 of the last 4 quarters.
The mean historical PE Ratio of Poseida Therapeutics, Inc. over the last ten years is 12.49. The current -15.08 PE Ratio has changed -12172.51% with respect to the historical average. Over the past ten years (40 quarters), PSTX's PE Ratio was at its highest in in the December 2021 quarter at 72.44K. The PE Ratio was at its lowest in in the December 2020 quarter at -4690.67.
Average
12.49
Median
-6.27
Minimum
-199.02
Maximum
261.23
Discovering the peaks and valleys of Poseida Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 261.23
Minimum Annual Increase = -4067.76%
Minimum Annual PE Ratio = -199.02
| Year | PE Ratio | Change |
|---|---|---|
| 2023 | -2.46 | -58.77% |
| 2022 | -5.96 | -106.19% |
| 2021 | 96.15 | -63.19% |
| 2020 | 261.23 | -4067.76% |
| 2019 | -6.58 | -46.99% |
| 2018 | -12.42 | -59.96% |
| 2017 | -31.02 | -84.41% |
The current PE Ratio of Poseida Therapeutics, Inc. (PSTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
29.25
5-year avg
68.48
10-year avg
12.49
Poseida Therapeutics, Inc.’s PE Ratio is less than Gracell Biotechnologies Inc. (-1.54), less than Harpoon Therapeutics, Inc. (-1.14), less than Albireo Pharma, Inc. (-5.61), less than Verve Therapeutics, Inc. (-12.19), less than Intercept Pharmaceuticals, Inc. (5.58), less than Crescent Biopharma, Inc. (-3.36), less than Chimerix, Inc. (-8.67), less than VectivBio Holding AG (-7.94), less than Avid Bioservices, Inc. (-5.61), less than Icosavax, Inc. (-6.88),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1.54 | $197.97M | |
| -1.14 | $865.08M | |
| -5.61 | $915.89M | |
| -12.19 | $994.04M | |
| 5.58 | $794.69M | |
| -3.36 | $494.09M | |
| -8.67 | $801.08M | |
| -7.94 | $1.06B | |
| -5.61 | $798.90M | |
| -6.88 | $769.04M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poseida Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Poseida Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Poseida Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Poseida Therapeutics, Inc. (PSTX)?
What is the highest PE Ratio for Poseida Therapeutics, Inc. (PSTX)?
What is the 3-year average PE Ratio for Poseida Therapeutics, Inc. (PSTX)?
What is the 5-year average PE Ratio for Poseida Therapeutics, Inc. (PSTX)?
How does the current PE Ratio for Poseida Therapeutics, Inc. (PSTX) compare to its historical average?